SALT LAKE CITY — When Angela Ibarra-Garcia went in for her 20-week ultrasound, she expected a routine checkup. Instead, she learned her baby girl, Daniela, had spina bifida, a condition where the ...
A Phase 1 clinical trial published in The Lancet reports that adding placenta-derived mesenchymal stromal cells (MSCs) to standard prenatal surgery for myelomeningocele (MMC) (1 Trusted Source ...
In utero treatment of myelomeningocele, the most severe form of spina bifida, with allogeneic, live stem cells was feasible and safe, a first-in-human, phase I trial suggested. All six infants had an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results